Search company, investor...

Athenix

athenixcorp.com

Founded Year

2000

Stage

Acquired | Acquired

Total Raised

$43.5M

Valuation

$0000 

About Athenix

Athenix is a biotechnology company that develops novel products and technologies for agricultural and industrial applications. Athenix has established an intellectual property portfolio and market access ability around enhanced plants, microbes, genes, enzymes, and processes with emphasis on two major markets: 1) novel agricultural traits for growers such as insect resistance, nematode resistance, herbicide tolerance, and their use for the crop production industry; and 2) the discovery of genes and proteins for use in the sustainable chemical industry.

Headquarters Location

108 T.W. Alexander Drive PO Box 110347

Durham, North Carolina, 27709,

United States

919-328-4100

Missing: Athenix's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Athenix's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Athenix

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Athenix is included in 1 Expert Collection, including Agriculture Technology (Agtech).

A

Agriculture Technology (Agtech)

1,903 items

Companies that are using technology to make farms more efficient.

Athenix Patents

Athenix has filed 1 patent.

The 3 most popular patent topics include:

  • Biotechnology
  • DNA
  • Genetics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/30/2017

12/29/2020

Molecular biology, Genetics, DNA, Biotechnology, Gene expression

Grant

Application Date

11/30/2017

Grant Date

12/29/2020

Title

Related Topics

Molecular biology, Genetics, DNA, Biotechnology, Gene expression

Status

Grant

Latest Athenix News

Nominations Open for the Annual Athenix Gives Back Program

Nov 7, 2022

Benzinga By Pr Com Athenix Body Sculpting Institute invites the public to nominate an Unsung Hero to receive a complimentary cosmetic procedure of their choosing. Aliso Viejo, CA November 07, 2022 --(PR.com)-- Athenix Body Sculpting Institute, a leading aesthetic plastic surgery practice with six locations across California, Oregon, and Washington, has launched its annual charitable program #AthenixGivesBack to honor Unsung Heroes in the community by gifting them with a complimentary cosmetic surgery makeover. Nominations are now open until November 30, 2022 at https://www.athenixbody.com/landing/athenix-gives-back/. AD AD Athenix invites the public to nominate an Unsung Hero in their lives - someone who may go unrecognized for their hard work, has made a positive impact in their community, or has selflessly provided for their family and deserves a reward for their efforts, to receive a complimentary cosmetic procedure. If chosen, both the nominee and the Unsung Hero will receive procedures of their choosing donated by Athenix.

Athenix Frequently Asked Questions (FAQ)

  • When was Athenix founded?

    Athenix was founded in 2000.

  • Where is Athenix's headquarters?

    Athenix's headquarters is located at 108 T.W. Alexander Drive, Durham.

  • What is Athenix's latest funding round?

    Athenix's latest funding round is Acquired.

  • How much did Athenix raise?

    Athenix raised a total of $43.5M.

  • Who are the investors of Athenix?

    Investors of Athenix include Bayer CropScience - Bromacil Herbicide Business, Polaris Partners, InterSouth Partners, Covera Ventures, Boston Millennia Partners and 5 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.